← Back to Search

Resistance Training for Type 1 Diabetes

N/A
Recruiting
Research Sponsored by University of Louisville
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Actively utilizing continuous glucose monitoring for diabetes management
≥ 13 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at how different resistance training programs can help regulate blood sugar in young athletes with Type 1 Diabetes Mellitus.

Who is the study for?
This trial is for young athletes who have had Type 1 Diabetes (T1DM) for at least two years, use continuous glucose monitoring, and are familiar with strength training. They must be over 13 years old and have an HbA1C level of 10% or lower. It's not suitable for those with physical limitations that affect exercise or non-English speakers.
What is being tested?
The study is examining how different resistance training programs impact blood sugar control in individuals with T1DM. Participants will engage in various strength-training exercises to see which regimen might be most beneficial.
What are the potential side effects?
While the trial itself does not involve medication and thus has no direct side effects like drugs do, participants may experience typical exercise-related discomforts such as muscle soreness or fatigue.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I use a continuous glucose monitor for my diabetes.
Select...
I am 13 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Assess glucose response to different resistance training methods
Secondary study objectives
To assess for correlation between lactate and glucose using different resistance training methods

Side effects data

From 2010 Phase 2 trial • 167 Patients • NCT00112151
66%
Other noncardiovascular serious adverse events
13%
Other nonserious adverse events
11%
Persistently elevated PSA
4%
Total serious cardiovascular adverse events
4%
Persistently elevated HCT >= 54%
2%
Elevated AUA
100%
80%
60%
40%
20%
0%
Study treatment Arm
Placebo
Lower-range T
Higher-range T

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Resistance TrainingExperimental Treatment1 Intervention
Bench press, Deadlift, Seated overhead press machine

Find a Location

Who is running the clinical trial?

University of LouisvilleLead Sponsor
348 Previous Clinical Trials
77,363 Total Patients Enrolled
Norton HealthcareOTHER
16 Previous Clinical Trials
2,846 Total Patients Enrolled

Media Library

Resistance Training Clinical Trial Eligibility Overview. Trial Name: NCT05315037 — N/A
Type 1 Diabetes Research Study Groups: Resistance Training
Type 1 Diabetes Clinical Trial 2023: Resistance Training Highlights & Side Effects. Trial Name: NCT05315037 — N/A
Resistance Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT05315037 — N/A
~3 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top